Equities

Sangani Hospitals Ltd

SANGANI:NSI

Sangani Hospitals Ltd

Actions
  • Price (INR)43.65
  • Today's Change-1.25 / -2.78%
  • Shares traded9.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024 10:56 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sangani Hospitals Limited is an India-based company, which is a multi-specialty healthcare provider operating in Keshod and Veraval regions of Gujarat. The Company’s services primarily include super specialty services, specialty services and other support services. The Company also operates a pathology laboratory and medical store. The Company operates two hospitals, which are Sangani Hospital at Keshod, Junagadh, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. Sangani Hospital is a 36 bed multi-specialty hospital with primary, secondary, and tertiary care facilities. Sangani Super Speciality Hospital is a 32 bed multi-specialty hospital with a significant focus on tertiary care facilities. Both the hospitals offer a comprehensive range of healthcare services in specialties and super specialties, including cardiac sciences, neurosciences, orthopedics, renal sciences and mother and childcare.

  • Revenue in INR (TTM)156.68m
  • Net income in INR14.84m
  • Incorporated2021
  • Employees--
  • Location
    Sangani Hospitals LtdSainath SocietyOpp., ST Bus Stand, KeshodJUNAGADH 362220IndiaIND
  • Phone+91 2 871235900
  • Websitehttps://sanganihospitals.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nidan Laboratories and Healthcare Ltd220.02m31.44m435.77m--13.890.61077.171.982.262.2615.8051.340.24984.833.73--3.57--3.89--95.31--14.29--1.608.040.1664---18.19--32.92------
Aatmaj Healthcare Ltd-100.00bn-100.00bn609.07m----5.53----------4.88------------------------1.59--0.4478--24.55--20.03------
Sangani Hospitals Ltd156.68m14.84m618.59m--41.693.4423.943.951.081.0811.3713.05----------------60.11--9.47--4.97--0.0056--52.36---32.38------
Maitreya Medicare Ltd-100.00bn-100.00bn862.58m----5.10----------24.97------------------------2.01--0.225---20.30--271.95------
Data as of Jun 07 2024. Currency figures normalised to Sangani Hospitals Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.